Insights On Clinical Technologies

  1. The AI Revolution In Clinical Trials 11/13/2025

    AI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.

  2. IQVIA IRT - Putting The Focus On Driving Value For Our Customers 2/27/2025

    IQVIA IRT senior leader and expert, Dan Pavitt, highlights key IRT initiatives aimed at enhancing customer value in this Clinical Leader Solutions Expo presentation.

  3. How Do Site Payments Impact Clinical Trial Sustainability? 4/16/2025

    Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,

  4. Overcoming Issues Of Non-Enrolling Sites In Clinical Trials 1/14/2025

    Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues.

  5. Accelerating CRO Study Deployment At Scale 7/7/2025

    A top-3 CRO and a top-10 pharmaceutical company partnered with Medable to help accelerate, scale, and standardize their eCOA trials. See how they accomplished it.

  6. A Long COVID Study Sponsor Adopts Integrated eCOA And Cognitive Assessment Solution 8/18/2025

    eCOA tools used in a long COVID study enabled remote, real-time symptom tracking, cognitive testing, and patient-reported outcomes, ensuring high-quality data while minimizing patient burden.

  7. Navigating The Enrollment Bottleneck In Early Oncology Trials 1/12/2026

    Slow oncology trial enrollment raises costs and delays progress. AI prescreening, patient-focused engagement, and early pharmacology studies help accelerate recruitment and optimize trial design.

  8. The FDA's Remote Regulatory Assessments: The Future Of Inspections 1/31/2025

    Remote Regulatory Assessments (RRAs) provide distinct advantages over traditional inspections, such as increased efficiency, reduced travel costs, and enhanced global oversight capabilities.

  9. Defining Meaningful Anti-Inflammatory Response: What Early Human Data Tells Us 9/22/2026

    Controlled immune challenges link drug exposure to biological effects, helping refine dose selection, test mechanisms and support better decisions before patient trials.

  10. Your IRB, Simplified: Fast, Friendly, And Focused 7/21/2026

    IRB approval does not have to be defined by delays or confusion. Learn how expert guidance, regulatory support, and modern technology can help research teams move forward with greater efficiency.